Jubilant HollisterStier wins Ocugen Covaxin supply contract

Jubilant HollisterStier will supply the COVID-19 vaccine Covaxin from its Spokane, Washington facility for Ocugen. The contract supports potential commercialization in the US and Canada.

“Securing US-based manufacturing capability is a critical step as we prepare to submit our regulatory submissions to the FDA and Health Canada.”bioprocessintl.com

• 1 source
• bioprocessintl.comJubilant HollisterStier wins Ocugen Covaxin contract - BioProcess InsiderDan StantonJun 17, 2021

Summarized from public sources; check the original articles before acting on it.